NeoGenomics to Provide MDx Testing to Aurora Diagnostics | GenomeWeb

NEW YORK (GenomeWeb) – Cancer genetics testing firm NeoGenomics today announced Aurora Diagnostics has selected it to be the primary partner for molecular testing in Aurora's US network of specialized pathology laboratories.

Aurora will be able to standardize oncology molecular testing services across its 19 labs as a result of the deal, NeoGenomics said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.